CD274 and cancer: Similar results were obtained previously by Topalian et al. [26], who showed that patients with various cancers with PD-L1 expression were more likely to obtain an objective response (36%, p = 0.006) and that PD-L1 expression below cut-off (<5%) was related to no response to anti-PD-1 therapy.